GO:0004915 |
Estrogen signaling pathway |
130.0E−3 |
6.12 |
[CALM3, CALML4, HSPA1L, HSPA8, ITPR3, MAPK3] |
GO:0004390 |
Hippo signaling pathway |
62.0E−3 |
5.84 |
[ACTG1, APC2, BIRC2, BMP2, FRMD6, LLGL2, RASSF6, SOX2, WNT8A] |
GO:0004520 |
Adherens junction |
290.0E−3 |
5.56 |
[ACTG1, MAPK3, PTPRM, WAS] |
GO:0004657 |
IL-17 signaling pathway |
220.0E−3 |
5.38 |
[IL6, MAPK15, MAPK3, S100A8, S100A9] |
GO:0004621 |
NOD-like receptor signaling pathway |
110.0E−3 |
5.29 |
[BIRC2, ERBIN, IFNA1, IFNAR2, IL6, ITPR3, MAPK3, RNASEL, TP53BP1] |
GO:0004210 |
Apoptosis |
210.0E−3 |
5.07 |
[ACTG1, BIRC2, ITPR3, LMNA, MAPK3, PDPK1, TUBA3D] |
GO:0004371 |
Apelin signaling pathway |
210.0E−3 |
5.07 |
[CALM3, CALML4, GNG11, ITPR3, MAPK3, PRKAG2, RYR2] |
GO:0004722 |
Neurotrophin signaling pathway |
270.0E−3 |
5.04 |
[CALM3, CALML4, IRAK2, MAGED1, MAPK3, PDPK1] |
GO:0004020 |
Calcium signaling pathway |
190.0E−3 |
4.95 |
[CALM3, CALML4, CHRM3, ITPR3, P2RX2, PTGER3, RYR2, SLC25A4, STIM2] |
GO:0004512 |
ECM–receptor interaction |
330.0E−3 |
4.88 |
[COL1A2, COL2A1, COL6A1, HSPG2] |
GO:0004620 |
Toll-like receptor signaling pathway |
380.0E−3 |
4.81 |
[IFNA1, IFNAR2, IL6, MAP2K3, MAPK3] |
GO:0004150 |
mTOR signaling pathway |
340.0E−3 |
4.61 |
[ATP6V1B2, DEPDC5, EIF4E, MAPK3, PDPK1, PRR5, WNT8A] |
GO:0004068 |
FoxO signaling pathway |
310.0E−3 |
4.55 |
[BCL6, CCNG2, IL6, MAPK3, PDPK1, PRKAG2] |
GO:0004510 |
Focal adhesion |
290.0E−3 |
4.52 |
[ACTG1, BCAR1, BIRC2, COL1A2, COL2A1, COL6A1, MAPK3, PARVB, PDPK1] |
GO:0004514 |
Cell adhesion molecules (CAMs) |
460.0E−3 |
4.14 |
[CADM1, CLDN5, NCAM2, PTPRC, PTPRM, SELP] |